What is a Treatment Arm in clinical trials?

A treatment arm is a defined group within a clinical trial to which participants are assigned according to the study protocol. Each arm represents a specific intervention, dosage, or control condition, allowing outcomes to be compared across groups to evaluate safety and effectiveness.

Treatment arms are used during study design and execution to organize how participants receive interventions. They are applied during randomization, treatment administration, safety evaluation, and efficacy analysis. Trials may include multiple arms, such as investigational treatment, placebo, or active comparator arms, depending on the study objectives and regulatory requirements.

Clinion implements treatment arms as structured study entities linked to protocol design, randomization logic, and RTSM configuration. Each arm is defined with associated rules such as allocation ratios, visit schedules, and dispensing logic. Treatment arms are mapped to coded identifiers to support blinded studies, while access controls determine which roles can view arm-level information. The system ensures arm assignments remain consistent across EDC, RTSM, and downstream study processes.

During study setup, treatment arms are configured based on the protocol. When a subject meets eligibility criteria, the site initiates randomization and the system assigns the subject to an arm according to predefined rules. Site staff follow the system-generated instructions for visits and dispensing without needing to reference arm definitions. Arm assignment is retained consistently across subject records, enabling accurate data collection and analysis without manual tracking.

Arm

Randomization

Blinding

Study Design

Investigational Product (IP)

Clinion eProtocol | AI-Powered Clinical Trial Protocol Generation

Study Setup & Design